Latest News

FDA OKs 1st Drug for Sinusitis With Nasal Polyps

illustration of sinusitis

Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis — defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.

Source link

Related posts

U.S. to quarantine all American citizens evacuated from Wuhan, as CDC raises pandemic possibility


Rude to your coworker? Think of the children


Frequent toilets at night are a sign of high blood pressure


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy